Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Consolidation Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002925
What this trial is testing

Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia

Who this might be right for
Leukemia
National Cancer Institute (NCI) 410
Testing effectiveness (Phase 2)Study completedNCT02405338
What this trial is testing

DC Vaccination for Post-remission Therapy in AML

Who this might be right for
Acute Myeloid Leukemia
Medigene AG 20
Early research (Phase 1)UnknownNCT03971214
What this trial is testing

PD-1 Inhibitors Consolidation in Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung CancerRadiotherapyImmunotherapy
Chinese Academy of Medical Sciences 6
Testing effectiveness (Phase 2)UnknownNCT01513109
What this trial is testing

Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia

Who this might be right for
Acute Myelogenous LeukemiaMyeloid Leukemia in RemissionEffects of Immunotherapy
Jules Bordet Institute 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783478
What this trial is testing

NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial

Who this might be right for
Acute Myeloid Leukaemia (AML)
Hospital de Clinicas de Porto Alegre 98
Testing effectiveness (Phase 2)Looking for participantsNCT06719700
What this trial is testing

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

Who this might be right for
ToripalimabSurufatinibChemoradiotherapy+1 more
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07759492
What this trial is testing

Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage III Unresectable
Intergroupe Francophone de Cancerologie Thoracique 177
Testing effectiveness (Phase 2)UnknownNCT04202809
What this trial is testing

Phase-II Trial of Induction Chemotherapy and Chemoradiotherapy Plus/Minus Durvalumab and Consolidation Immunotherapy in Patients With Resectable Stage III NSCLC.

Who this might be right for
NSCLC, Stage III
University Hospital, Essen 90
Testing effectiveness (Phase 2)Looking for participantsNCT06985485
What this trial is testing

Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy

Who this might be right for
Acute Lymphoblastic LeukemiaImmunotherapyBlinatumomab+1 more
The First Affiliated Hospital of Soochow University 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07569965
What this trial is testing

Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCL

Who this might be right for
Mantle Cell Lymphoma (MCL)
Miltenyi Biomedicine GmbH 52
Large-scale testing (Phase 3)Looking for participantsNCT07678229
What this trial is testing

BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma
Rong Tao 150
Large-scale testing (Phase 3)Study completedNCT00006363
What this trial is testing

Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Erythroid Leukemia (M6)+30 more
National Cancer Institute (NCI) 720
Large-scale testing (Phase 3)Not Yet RecruitingNCT06719336
What this trial is testing

Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001)

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Anhui Shi, MD 182
Testing effectiveness (Phase 2)Looking for participantsNCT07575971
What this trial is testing

Exploratory Study of CD22/CD19 Dual-Target CAR-T Cell Therapy as Consolidation Treatment After First Remission in High-Risk B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Liping Dou 30
Large-scale testing (Phase 3)Temporarily pausedNCT04402788
What this trial is testing

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Who this might be right for
Extensive Stage Lung Small Cell Carcinoma
National Cancer Institute (NCI) 138
Testing effectiveness (Phase 2)UnknownNCT06498752
What this trial is testing

MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102
Testing effectiveness (Phase 2)Study completedNCT00558220
What this trial is testing

R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas

Who this might be right for
Diffuse Large B-Cell Lymphoma.Primary Mediastinal B-Cell LymphomaFollicular Lymphoma Grade III
Czech Lymphoma Study Group 106
Post-approval studies (Phase 4)Looking for participantsNCT06908070
What this trial is testing

Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab

Who this might be right for
Non-small Cell Lung Cancer Stage III
Idris Bahce 38
Not applicableNot Yet RecruitingNCT07035860
What this trial is testing

Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Carbon Ion Radiotheray
Ji Yongling 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT06219317
What this trial is testing

Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC

Who this might be right for
NSCLC Stage IV
European Organisation for Research and Treatment of Cancer - EORTC 136
Next Page